| P2093 | author name string | Gang Chen | |
| | Xin Zhang | |
| | Dianzhong Luo | |
| | Yiwu Dang | |
| | Fanghui Ren | |
| | Haiwei Liang | |
| | Minhua Rong | |
| P2860 | cites work | Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression. | Q50658268 |
| | Prognostic value of microRNA-10b overexpression in peripheral blood mononuclear cells of nonsmall-cell lung cancer patients. | Q52951826 |
| | miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer. | Q53007110 |
| | miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. | Q53306726 |
| | Correlation between down-expression of miR-431 and clinicopathological significance in HCC tissues. | Q53576820 |
| | MicroRNA-141 is a biomarker for progression of squamous cell carcinoma and adenocarcinoma of the lung: clinical analysis of 125 patients. | Q53587285 |
| | MicroRNA-34a expression is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma. | Q53642072 |
| | Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL. | Q54235737 |
| | miRNA27a is a biomarker for predicting chemosensitivity and prognosis in metastatic or recurrent gastric cancer. | Q54239648 |
| | MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma | Q57247811 |
| | DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer | Q83557235 |
| | Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer | Q83943066 |
| | [Association between miR-34a expression and recurrence after radical resection of colorectal cancer] | Q85965824 |
| | JMJD2A predicts prognosis and regulates cell growth in human gastric cancer | Q87823319 |
| | Hallmarks of Cancer: The Next Generation | Q22252312 |
| | Prognostic significance of differentially expressed miRNAs in esophageal cancer | Q24612881 |
| | MicroRNA-34a: a potential therapeutic target in human cancer | Q27003249 |
| | Global cancer statistics, 2012 | Q27860501 |
| | microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma. | Q30570563 |
| | Reduced expression of miRNA-1237-3p associated with poor survival of spinal chordoma patients | Q33275607 |
| | miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan | Q33773806 |
| | MicroRNA expression and clinical outcome of small cell lung cancer | Q33952288 |
| | MiR-34a expression has an effect for lower risk of metastasis and associates with expression patterns predicting clinical outcome in breast cancer | Q34079217 |
| | MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma | Q34268278 |
| | Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma | Q35137803 |
| | MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance | Q35537955 |
| | High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis | Q35552790 |
| | Decreased Expression of miR-15b in Human Gliomas is Associated with Poor Prognosis | Q35589764 |
| | microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer. | Q35793647 |
| | Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence | Q35799910 |
| | A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ. | Q35832201 |
| | MiR-34b is associated with clinical outcome in triple-negative breast cancer patients | Q35950656 |
| | Phytochemical regulation of the tumor suppressive microRNA, miR-34a, by p53-dependent and independent responses in human breast cancer cells | Q36998944 |
| | Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review | Q37967610 |
| | The analysis of microRNA-34 family expression in human cancer studies comparing cancer tissues with corresponding pericarcinous tissues | Q38276167 |
| | miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression | Q38972595 |
| | The RNA-binding protein PCBP2 facilitates gastric carcinoma growth by targeting miR-34a | Q38998575 |
| | miR-34 is associated with poor prognosis of patients with gallbladder cancer through regulating telomere length in tumor stem cells | Q39089969 |
| | MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment | Q39124552 |
| | miR-34a is downregulated in cis-diamminedichloroplatinum treated sinonasal squamous cell carcinoma patients with poor prognosis. | Q39342904 |
| | miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy | Q39465507 |
| | Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer | Q39592978 |
| | MicroRNA profiling of gastric cancer patients from formalin-fixed paraffin-embedded samples | Q42252202 |
| | Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and β-catenin predicts distant metastasis of colon cancer | Q45159574 |
| | Pretreatment MicroRNA Level and Outcome in Sorafenib-treated Hepatocellular Carcinoma. | Q46124376 |
| | Expression level of human miR-34a correlates with glioma grade and prognosis | Q48110181 |
| P433 | issue | 10 | |
| P304 | page(s) | 17377-17391 | |
| P577 | publication date | 2015-10-15 | |
| P1433 | published in | International Journal of Clinical and Experimental Medicine | Q6051338 |
| P1476 | title | Prognostic significance of MiR-34a in solid tumors: a systemic review and meta-analysis with 4030 patients | |
| P478 | volume | 8 | |